Novelion Therapeutics, Inc. (Nasdaq: NVLN) announced that its subsidiary, Aegerion Pharmaceuticals, Inc., has entered into a licensing agreement with Amryt ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE